In the United States, 79 million men and women each year are infected by human papillomavirus (HPV), accounting for more than 4,000 deaths from cervical cancer. Following the development of the first HPV vaccine, the Centers for Disease Control and Prevention set a goal to get 80 percent of female adolescents vaccinated. However, despite the vaccine’s demonstrated efficacy, vaccination rates have only reached 38 percent nationally and 32 percent in Texas. A panel discussion hosted by the Baker Institute Science and Technology Policy Program will bring together leaders from academia, government and the media to discuss HPV, its impact on cancer and other diseases, and opportunities and challenges associated with prevention through vaccination programs.
Click here to register for "HPV Vaccination: A Public Health Opportunity, a Public Responsibility" on Wednesday, Dec. 3, 2014.
This panel discussion is the sixth event in the Medicine, Research and Society Policy Issues Series, a joint project with the Baker Institute Science and Technology Policy Program, the Health Policy Forum and The University of Texas MD Anderson Cancer Center.